MeMed

About

At MeMed, a leader in host response technologies, we decode the body’s complex signals into simple insights that improve people’s lives. By leveraging expertise in host-response profiling and machine-learning algorithms, MeMed is creating a portfolio of tests that address tough clinical dilemmas. The FDA-cleared MeMed BV® is a novel assay that can distinguish between bacterial and viral infection, enabling improved patient management, including appropriate antibiotic use, helping address the global healthcare challenge of antimicrobial resistance. Run on the MeMed Key®, MeMed BV delivers fast, accurate results in 15 minutes from a serum sample.

Business Hours